Three Different Types of Thermometers in Measuring Temperature in Young Patients With Fever and Without Fever
RATIONALE: Comparing results of three different thermometers used to measure body temperature may help doctors find the most accurate thermometer to detect fever and plan the best treatment.
PURPOSE: This clinical trial is studying three different types of thermometers to measure temperature in young patients with fever and without fever.
|Study Design:||Primary Purpose: Diagnostic|
|Official Title:||A Study Evaluating the Agreement of Devices for Measuring Temperature in Children|
- Agreement between the temporal artery scanner, digital oral thermometer, and infrared tympanic thermometer calibrated to an oral setting in pediatric patients who are febrile and afebrile [ Designated as safety issue: No ]
- Similarities or differences in the percent of fevers detected with oral, ear, and temporal artery monitoring [ Designated as safety issue: No ]
- Differences in agreement of the various temperature devices [ Designated as safety issue: No ]
|Study Start Date:||March 2006|
|Study Completion Date:||November 2009|
- Determine agreement between three different types of temperature-measuring instruments: the temporal artery scanner, the digital oral thermometer, and the infrared tympanic thermometer calibrated to an oral setting, in pediatric patients who are febrile and afebrile.
- Determine similarities or differences in the percent of fevers detected with oral, ear, and temporal artery monitoring in these pediatric patients.
- Determine differences in agreement of the various temperature devices in non-neutropenic pediatric patients versus neutropenic pediatric patients.
OUTLINE: This is a prospective study.
During an afebrile episode, the patient's temperature is measured twice using the following 3 devices: a temporal artery scanner, a digital oral thermometer, and an infrared tympanic thermometer calibrated to an oral setting (total of 6 temperature measurements per afebrile episode).
During a febrile episode, the patient's temperature is measured twice using all 3 devices as above, and then at 2 and 4 hours after administration of an antipyretic medication (total of 18 temperatures per febrile episode).
Patients' temperatures are recorded for a maximum of 3 afebrile or febrile episodes.
PROJECTED ACCRUAL: A total of 32 patients will be accrued for this study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00378846
|United States, Maryland|
|Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office|
|Bethesda, Maryland, United States, 20892-1182|
|Principal Investigator:||Thomas J. Walsh, MD||National Cancer Institute (NCI)|